Besides, among the GO and pathway analysis in this study, the differentially expressed circRNAs were identified as having potential roles in multiple pathways implicated in cancer initiation and progression, including RNA degradation and MDM2-p53 pathways, suggesting that the development of sorafenib resistance in HCC aids tumor progression. This evidence concerns the gene MDM2 and hepatocellular carcinoma.